Skip to main content
logo
Sheel Biotech Limited (NSE:SHEEL)
India flag India · Delayed Price · Currency is INR
60.00
0.00 (0.00%)
At close: Oct 5, 2026

Sheel Biotech Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,1001,1001,018922.82801.16707.36
Revenue Growth
-2.05%8.13%10.26%15.19%13.26%12.23%
Gross Profit
405.9405.9360.37346.6259.73229.09
Operating Income
198.14198.14141.11135.4978.1755.3
Net Income
117.56117.56107.55104.7550.7748.57
Earnings Per Share
6.696.697.287.223.503.35
EPS Growth
-32.71%-8.10%0.83%106.29%4.51%-65.58%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
91.7891.7820.718.314.73.11
Total Debt
89.7989.79173.61235.4191.71235.83
Net Cash (Debt)
1.991.99-152.91-217.1-177.01-232.72
Net Cash Growth
------
Net Cash Per Share
0.110.11-10.35-14.97-12.20-16.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-175.69-175.6985.15-9.292.9221.91
Capital Expenditures
-66.6-66.6-12.38-2.94-11.55-12.09
Free Cash Flow
-242.28-242.2872.76-12.1481.389.81
Free Cash Flow Growth
----729.34%-

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
36.89%36.89%35.42%37.56%32.42%32.39%
Operating Margin
18.01%18.01%13.87%14.68%9.76%7.82%
Pretax Margin
12.74%12.74%12.60%13.28%7.95%6.86%
Profit Margin
10.69%10.69%10.57%11.35%6.34%6.87%
FCF Margin
-22.02%-22.02%7.15%-1.31%10.16%1.39%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
8.976.93----
PS Ratio
1.110.74----